Support for a Paediatric Investigation Plan in the European Union, for a US-based client

- 2 November 2020

BlueReg Group Support for a Paediatric Investigation Plan in the European Union, for a US-based client

Support for a Paediatric Investigation Plan in the European Union, for a US-based client

Read our latest PIP case study following our recent webinar!

 

Discover how BlueReg provided support for a Paediatric Investigation Plan (PIP) in the European Union, for a US-based client.

 

BlueReg initially provided guidance with the paediatric regulatory strategy and its potential impact on the PIP Application positioning.

 

Subsequently, BlueReg wrote the PIP Scientific Document and prepared the ready-for-submission PIP Application.

 

Did you like this article? Share on social networks:


    By sending this form, I agree that my personal data will be saved and processed according to data protection regulations and will be used only for commercial and marketing purposes only.

    Learn more


    BlueReg undertakes to comply with the regulations in force applicable to the processing of personal data and, in particular, Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 applicable as from 25 May 2018 (hereinafter, "the General Data Protection Regulations" or GPDR) and the national laws resulting therefrom.
    Any inquiries, correction or declaration of event related to personal data processed should be sent to: GDPR data request

    Thank you for your reply

    The file will be sent to you by email.

    Download

    Contact our experts today

    Composed of proven experts from the pharmaceutical industry, our team is ready to answer to your needs in any area of product development, commercialisation and early access programs, and life cycle management

    Make an enquiry